BIO Congratulates Congressman Henry Waxman as Incoming Chairman of the House Energy and Commerce Committee
WASHINGTON, D.C. (Thursday, November 20, 2008) - The following statement was issued today by Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood following the election of Congressman Henry Waxman (D-CA) as the new Chairman of the Energy and Commerce Committee of the House of Representatives:
“BIO congratulates Chairman Waxman on his new position. As Chairman, Congressman Waxman will oversee a wide array of legislative issues that relate to biotechnology innovation. We look forward to working with the Chairman and the full committee to create a public policy framework that helps enable our nation’s biotechnology community to continue to develop groundbreaking therapies, cures and applications that help save and extend the lives of patients suffering from debilitating diseases, reduce greenhouse gas emissions, expand sources of renewable fuels and increase agricultural sustainability while creating high-skill, high wage, green jobs.
“During my twelve years in the House of Representatives, I worked closely with Congressman Waxman on the Energy and Commerce Subcommittee on Health. I look forward to continuing our friendship and the spirit of collaboration we enjoyed while we served together.
“We also commend Congressman John Dingell (D-MI) for his decades of service as Chairman of the Energy and Commerce Committee. We look forward to working closely with Congressman Dingell and his staff during the new Congress.”
Upcoming BIO Events
BIO-Asia Partnering Conference 2009
January 19-20, 2009
Tokyo, Japan
BIO CEO & Investor Conference 2009
February 9-10, 2009
New York, New York
BIO-Europe Spring
March 16-18, 2009
Milan, Italy
BIO Windhover 2009
April 13-15, 2009
New York, New York
2009 BIO International Convention
May 18-21, 2009
Atlanta, Ga.
BioEquity Europe
June 9-10, 2009
Munich, Germany
World Congress on Industrial Biotechnology & Bioprocessing
July 19-22, 2009
Montreal, Quebec, Canada
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
###